Literature DB >> 20647789

Managing antimicrobial resistance in intensive care units.

Tejal N Gandhi1, Daryl D DePestel, Curtis D Collins, Jerod Nagel, Laraine L Washer.   

Abstract

The challenges in managing patients with infection in the intensive care unit are increased in an era where there are dwindling antimicrobial choices for multidrug-resistant pathogens. Clinicians in the intensive care unit must balance between choosing appropriate antimicrobial treatment for patients with suspected infection and utilizing antimicrobials in a judicious fashion. Improving antimicrobial utilization is a critical component to reducing antimicrobial resistance. Although providing effective antimicrobial therapy and improving antimicrobial utilization may seem to be competing goals, there are effective strategies to accomplish both. Antimicrobial stewardship programs provide an organized way to implement these strategies and can enhance the intensive care unit physician's success in improving patient outcomes and combating antimicrobial resistance in the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647789     DOI: 10.1097/CCM.0b013e3181e6a2a4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Understanding antibiotic stewardship for the critically ill.

Authors:  J J De Waele; J Schouten; G Dimopoulos
Journal:  Intensive Care Med       Date:  2015-08-20       Impact factor: 17.440

Review 2.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

3.  New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging.

Authors:  Jean-Marie Pagès; Slavka Kascàkovà; Laure Maigre; Anas Allam; Mickael Alimi; Jacqueline Chevalier; Erwan Galardon; Matthieu Réfrégiers; Isabelle Artaud
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

4.  Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.

Authors:  Tomefa E Asempa; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 5.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

Review 6.  Antimicrobial therapy in resource-limited settings with high antimicrobial resistance: a case-based approach.

Authors:  Nitin Gupta
Journal:  Infez Med       Date:  2022-03-01

7.  Verigene® gram-positive blood culture nucleic acid test.

Authors:  Lesley J Scott
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074

8.  Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution.

Authors:  Slávka Kaščáková; Laure Maigre; Jacqueline Chevalier; Matthieu Réfrégiers; Jean-Marie Pagès
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

9.  Antibacterial activities of Beilschmiedia obscura and six other Cameroonian medicinal plants against multi-drug resistant Gram-negative phenotypes.

Authors:  Aimé G Fankam; Jules R Kuiate; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2014-07-14       Impact factor: 3.659

10.  An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients.

Authors:  Christina M Katsios; Lisa Burry; Sandra Nelson; Tanaz Jivraj; Stephen E Lapinsky; Randy S Wax; Michael Christian; Sangeeta Mehta; Chaim M Bell; Andrew M Morris
Journal:  Crit Care       Date:  2012-11-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.